Firstly, we observed the upregulation of SRSF9 expression in GBM tissues comparing to their adjacent normal controls and found that elevated SRSF9 expression correlates with glioma progression and poor patient prognosis. This evidence concerns the gene SRSF9 and central nervous system cancer.